Shin JH et al. |
The effect of topical FK506 (tacrolimus) in a mouse model of allergic rhinitis. |
2012 Mar-Apr |
Am J Rhinol Allergy |
pmid:22487280
|
Reams BD and Palmer SM |
Sublingual tacrolimus for immunosuppression in lung transplantation: a potentially important therapeutic option in cystic fibrosis. |
2002 |
Am J Respir Med |
pmid:14720063
|
Lee J et al. |
Inpatient rehabilitation challenges in a quadrimembral amputee after bilateral hand transplantation. |
2011 |
Am J Phys Med Rehabil |
pmid:21765280
|
Laifer SA et al. |
Pregnancy after cardiac transplantation. |
1994 |
Am J Perinatol |
pmid:7519426
|
Tulaci KG et al. |
The effect of tacrolimus on facial nerve injury: Histopathological findings in a rabbit model. |
|
Am J Otolaryngol |
pmid:27465503
|
Knott PD et al. |
Induction with T-cell receptor antibody leads to long-term laryngeal allograft function. |
2008 Nov-Dec |
Am J Otolaryngol |
pmid:19144301
|
Yang GS et al. |
Intratympanic immunosuppressives for prevention of immune-mediated sensorineural hearing loss. |
2000 |
Am J Otol |
pmid:10912694
|
Pezze JL and Whiteman K |
Transplantation's newest weapon FK 506. |
1991 |
Am J Nurs |
pmid:1716857
|
Taormina D et al. |
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers. |
1992 |
Am J Hosp Pharm |
pmid:1373936
|
Min DI et al. |
Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection. |
1992 |
Am J Hosp Pharm |
pmid:1282779
|
|
Tacrolimus introduced for use in liver transplantation. |
1994 |
Am J Hosp Pharm |
pmid:7524317
|
Przepiorka D et al. |
Blood tacrolimus concentration unchanged by plasmapheresis. |
1994 |
Am J Hosp Pharm |
pmid:7524318
|
Matsunami H et al. |
New technique for measuring tacrolimus concentrations in blood. |
1994 |
Am J Hosp Pharm |
pmid:7510929
|
|
Roche, FDA announce new drug-interaction warnings for mibefradil. |
1998 |
Am J Health Syst Pharm |
pmid:9492249
|
Ku YM et al. |
Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection. |
1995 |
Am J Health Syst Pharm |
pmid:8528874
|
Greanya ED et al. |
Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen. |
2012 |
Am J Health Syst Pharm |
pmid:22215359
|
Heavner MS et al. |
Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients. |
2013 |
Am J Health Syst Pharm |
pmid:23943182
|
Curtin BF et al. |
Unusually late-onset mycophenolate mofetil-related colitis. |
2014 |
Am J Health Syst Pharm |
pmid:25320135
|
Bonhomme-Faivre L et al. |
Effect of the ABCB1 3435C>T polymorphism on tacrolimus concentrations and dosage requirements in liver transplant recipients. |
2009 |
Am J Health Syst Pharm |
pmid:19729569
|
Lee JH et al. |
Stability of tacrolimus solutions in polyolefin containers. |
2016 |
Am J Health Syst Pharm |
pmid:26796907
|
|
Tacrolimus. |
2001 |
Am J Health Syst Pharm |
pmid:11794952
|
Lee B et al. |
Appropriate timing of tacrolimus concentration measurements in the emergency department. |
2016 |
Am J Health Syst Pharm |
pmid:27543574
|
Jacobson PA et al. |
Stability of tacrolimus in an extemporaneously compounded oral liquid. |
1997 |
Am J Health Syst Pharm |
pmid:9117806
|
Utecht KN et al. |
Effects of genetic polymorphisms on the pharmacokinetics of calcineurin inhibitors. |
2006 |
Am J Health Syst Pharm |
pmid:17106006
|
Kelly PA et al. |
Tacrolimus: a new immunosuppressive agent. |
1995 |
Am J Health Syst Pharm |
pmid:7552894
|
MacDonald AS and Sketris IS |
Tacrolimus in transplantation. |
1995 |
Am J Health Syst Pharm |
pmid:7552906
|
Johnson CE et al. |
Stability of tacrolimus with morphine sulfate, hydromorphone hydrochloride, and ceftazidime during simulated intravenous coadministration. |
1999 |
Am J Health Syst Pharm |
pmid:10030533
|
Pennington CA and Park JM |
Sublingual tacrolimus as an alternative to oral administration for solid organ transplant recipients. |
2015 |
Am J Health Syst Pharm |
pmid:25631834
|
Tsapepas DS et al. |
Managing the atazanavir-tacrolimus drug interaction in a renal transplant recipient. |
2011 |
Am J Health Syst Pharm |
pmid:21200061
|
Myers AL et al. |
Stability of tacrolimus injection diluted in 0.9% sodium chloride injection and stored in Excel bags. |
2016 |
Am J Health Syst Pharm |
pmid:27919876
|
Grouzmann E et al. |
Misleading tacrolimus concentration value in blood taken from a catheter used for tacrolimus administration. |
2008 |
Am J Health Syst Pharm |
pmid:18216007
|
Kasper RC et al. |
Anetoderma arising in cutaneous B-cell lymphoproliferative disease. |
2001 |
Am J Dermatopathol |
pmid:11285407
|
Breuer K et al. |
Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. |
2005 |
Am J Clin Dermatol |
pmid:15799678
|
Gupta AK and Versteeg SG |
Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review. |
2017 |
Am J Clin Dermatol |
pmid:27804089
|
Kalavala M and Dohil MA |
Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence. |
2011 |
Am J Clin Dermatol |
pmid:21067248
|
Yang LP and Curran MP |
Spotlight on topical pimecrolimus in pediatric atopic dermatitis. |
2010 |
Am J Clin Dermatol |
pmid:20509720
|
Cheer SM and Plosker GL |
Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis. |
2001 |
Am J Clin Dermatol |
pmid:11770393
|
Ozden MG et al. |
Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study. |
2010 |
Am J Clin Dermatol |
pmid:20000875
|
Patel TS et al. |
Cancer concerns with topical immunomodulators in atopic dermatitis: overview of data and recommendations to clinicians. |
2007 |
Am J Clin Dermatol |
pmid:17645374
|
Mertens JS et al. |
Morphea and Eosinophilic Fasciitis: An Update. |
2017 |
Am J Clin Dermatol |
pmid:28303481
|
Frankel HC and Qureshi AA |
Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis. |
2012 |
Am J Clin Dermatol |
pmid:22263704
|
Iskedjian M et al. |
Topical calcineurin inhibitors in the treatment of atopic dermatitis: a meta-analysis of current evidence. |
2004 |
Am J Clin Dermatol |
pmid:15301573
|
Kroft EB et al. |
Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study. |
2009 |
Am J Clin Dermatol |
pmid:19354332
|
Siegfried EC et al. |
Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice. |
2013 |
Am J Clin Dermatol |
pmid:23703374
|
Tjioe M et al. |
Topical macrolide immunomodulators: a role in the treatment of vitiligo? |
2006 |
Am J Clin Dermatol |
pmid:16489839
|
Valdivielso-Ramos M et al. |
Significant improvement in extensive lichen sclerosus with tacrolimus ointment and PUVA. |
2008 |
Am J Clin Dermatol |
pmid:18429647
|
Wellington K and Noble S |
Pimecrolimus: a review of its use in atopic dermatitis. |
2004 |
Am J Clin Dermatol |
pmid:15663345
|
Cook BA and Warshaw EM |
Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis: a review of pathophysiology, safety, and efficacy. |
2009 |
Am J Clin Dermatol |
pmid:19222250
|
Ingram JR et al. |
Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis. |
2009 |
Am J Clin Dermatol |
pmid:19489656
|
Reitamo S et al. |
Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis. |
2002 |
Am J Clin Dermatol |
pmid:12113647
|
Wellington K and Jarvis B |
Spotlight on topical pimecrolimus in atopic dermatitis. |
2002 |
Am J Clin Dermatol |
pmid:12113651
|
Lübbe J et al. |
Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practice. |
2006 |
Am J Clin Dermatol |
pmid:16605292
|
Ellis CN et al. |
Cost effectiveness of management of mild-to-moderate atopic dermatitis with 1% pimecrolimus cream in children and adolescents 2-17 years of age. |
2006 |
Am J Clin Dermatol |
pmid:16605293
|
Wollina U |
The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis. |
2007 |
Am J Clin Dermatol |
pmid:17492844
|
Ramirez R et al. |
Posterior Reversible Encephalopathy Syndrome After Orthotopic Heart Transplantation: A Case Report. |
2017 |
Am J Case Rep |
pmid:28465499
|
Kawamura H et al. |
Rapid Induction Therapy with Oral Tacrolimus in Elderly Patients with Refractory Ulcerative Colitis Can Easily Lead to Elevated Tacrolimus Concentrations in Blood: A Report of 5 Cases. |
2017 |
Am J Case Rep |
pmid:28411286
|
Udomkarnjananun S et al. |
An Unusual Manifestation of Calcineurin Inhibitor-Induced Pain Syndrome in Kidney Transplantation: A Case Report and Literature Review. |
2018 |
Am J Case Rep |
pmid:29654227
|
Baran DA et al. |
Calcineurin inhibitor-associated early renal insufficiency in cardiac transplant recipients: risk factors and strategies for prevention and treatment. |
2004 |
Am J Cardiovasc Drugs |
pmid:14967063
|
Mcauliffe EP |
Is tacrolimus the best therapy for atopic dermatitis? |
2003 |
Am Fam Physician |
pmid:12751651
|
Lane JE and Johnson J |
Persistent penile patch. |
2008 |
Am Fam Physician |
pmid:19007056
|
Russell JJ |
Topical tacrolimus: a new therapy for atopic dermatitis. |
2002 |
Am Fam Physician |
pmid:12469964
|
Berke R et al. |
Atopic dermatitis: an overview. |
2012 |
Am Fam Physician |
pmid:22962911
|
Hitzeman N and Kinnevey C |
Topical Tacrolimus for Eczema. |
2016 |
Am Fam Physician |
pmid:27929217
|
Wilhelmi E et al. |
Organotypic brain-slice cultures from adult rats: approaches for a prolonged culture time. |
2002 May-Jun |
Altern Lab Anim |
pmid:12106005
|
Kay AB |
Immunosuppressive agents in chronic severe asthma. |
1994 May-Jun |
Allergy Proc |
pmid:7523242
|
Leonardi S et al. |
Efficacy and safety of tacrolimus ointment 0.03% treatment in a 1-month-old "red baby": a case report. |
2006 Nov-Dec |
Allergy Asthma Proc |
pmid:17176789
|
Pacor ML et al. |
Tacrolimus ointment in nickel sulphate-induced steroid-resistant allergic contact dermatitis. |
2006 Nov-Dec |
Allergy Asthma Proc |
pmid:17176790
|
Rico MJ and Lawrence I |
Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects. |
2002 May-Jun |
Allergy Asthma Proc |
pmid:12125507
|
Szema AM |
Angioedema in a child with a liver transplant, intussusception, and normal c4 levels. |
2010 Jul-Aug |
Allergy Asthma Proc |
pmid:20615276
|
Wollenberg A et al. |
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. |
2008 |
Allergy |
pmid:18445188
|
Jensen JM et al. |
Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis. |
2012 |
Allergy |
pmid:22142306
|
Bieber T et al. |
Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. |
2007 |
Allergy |
pmid:17298428
|
Wollenberg A et al. |
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. |
2008 |
Allergy |
pmid:18592619
|
Bergstrand H and Lundquist B |
Human basophil histamine release is differently affected by inhibitors of calmodulin, diacylglycerol kinase and peptidyl prolyl cis-trans isomerase in a secretagogue specific manner. |
1992 |
Allergy |
pmid:1280915
|
Kaufmann R et al. |
Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial. |
2006 |
Allergy |
pmid:16436149
|
Oldhoff JM et al. |
Modulation of the atopy patch test: tacrolimus 0.1% compared with triamcinolone acetonide 0.1%. |
2006 |
Allergy |
pmid:16629794
|
Simon D et al. |
Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment. |
2005 |
Allergy |
pmid:15932386
|
Inoue Y et al. |
Food allergy after cord blood stem cell transplantation with tacrolimus therapy in two patients who developed veno-occlusive disease. |
2012 |
Allergol Int |
pmid:22722810
|
Tsuji T et al. |
Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice. |
2016 |
Allergol Int |
pmid:26666476
|
Miyachi Y et al. |
Suplatast/tacrolimus combination therapy for refractory facial erythema in adult patients with atopic dermatitis: a meta-analysis study. |
2007 |
Allergol Int |
pmid:17582208
|
Ebihara N et al. |
Blood level of tacrolimus in patients with severe allergic conjunctivitis treated by 0.1% tacrolimus ophthalmic suspension. |
2012 |
Allergol Int |
pmid:22361511
|
Yamamoto M et al. |
A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. |
2007 |
Allergol Int |
pmid:17460441
|
Ortiz de Frutos FJ |
[New horizons in the treatment of atopic dermatitis]. |
|
Allergol Immunopathol (Madr) |
pmid:11988144
|
Mori F et al. |
Increase of natural killer cells in children with liver transplantation-acquired food allergy. |
|
Allergol Immunopathol (Madr) |
pmid:29456038
|
Regueiro-GarcÃa A et al. |
Haploidentical stem cell transplantation in a boy with chronic granulomatous disease. |
|
Allergol Immunopathol (Madr) |
pmid:29373243
|
Ierardi E et al. |
Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11207512
|
Itoh S et al. |
Inhibition of CN (protein phosphatase-2B) suppresses Ca2+-mediated acid secretion in rats. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11966520
|
Firpi RJ et al. |
Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:15113371
|
Hisanaga Y et al. |
Implication of nitric oxide synthase activity in the genesis of water immersion stress-induced gastric lesions in rats: the protective effects of FK506. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971291
|
Högenauer C et al. |
Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12940927
|
Trotter JF et al. |
Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipients. |
2005 |
Aliment. Pharmacol. Ther. |
pmid:15963078
|
Nakase H et al. |
Tacrolimus suppresses IL-12/IL23 p40 in Crohn's disease and heals fistulae refractory to anti-TNF-α therapy. |
2011 |
Aliment. Pharmacol. Ther. |
pmid:21434949
|
Nakase H et al. |
Tacrolimus: rescue therapy or experimental drug for severe ulcerative colitis? |
2011 |
Aliment. Pharmacol. Ther. |
pmid:21198700
|
Yamamoto T et al. |
Letter: which patient profile for tacrolimus in ulcerative colitis? Authors' reply. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27137731
|
Laharie D and Poullenot F |
Letter: which patient profile for tacrolimus in ulcerative colitis? |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27137730
|
Hoshino H et al. |
Effects of FK506 on an experimental model of colitis in rats. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7544633
|
Lawrance IC and Copeland TS |
Rectal tacrolimus in the treatment of resistant ulcerative proctitis. |
2008 |
Aliment. Pharmacol. Ther. |
pmid:18761706
|
Liberal R et al. |
Expert clinical management of autoimmune hepatitis in the real world. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28004405
|
Segal JP et al. |
Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28008631
|
Yamamoto T et al. |
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis--authors' reply. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27040167
|